共 50 条
- [1] EFFECT OF BASELINE PROSTATE CANCER RISK ON DUTASTERIDE EFFICACY IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDYEUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 300 - 301Marberger, M.Pettaway, C.Tammela, T.Tindall, D. J.Teloken, C.Wilson, T. H.Castro, R.
- [2] Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study.JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Brawley, O. W.Andriole, G. L.Teloken, C.Somerville, M. C.Gagnier, R. P.
- [3] THE UTILITY OF PSA FOR DETECTION OF PROSTATE CANCER IN MEN TRLATED WITH DUTASTERIDE RESULTS FROM THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDYJOURNAL OF MENS HEALTH, 2009, 6 (03) : 269 - 269Andriole, G. L.Bostwick, D.Brawley, O.Gomella, L.Marberger, M.Montorsi, F.Pettaway, C.Tammela, T.Teloken, C.Tindall, D.Wilson, T. H.Somerville, M.Fowler, I.Rittmaster, R. S.
- [4] EFFICACY OF DUTASTERIDE ON BENIGN PROSTATIC HYPERPLASIA ENDPOINTS IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY ACCORDING TO BASELINE INTERNATIONAL PROSTATE SYMPTOM SCORE AND PROSTATE VOLUMEJOURNAL OF UROLOGY, 2010, 183 (04): : E691 - E691Roehrborn, Claus G.Pettaway, Curtis A.Nickel, J. CurtisTammela, Teuvo L. J.Teloken, ClaudioSomerville, Matthew C.Wilson, Timothy H.Rittmaster, Roger S.
- [5] DUTASTERIDE REDUCES PROSTATITIS SYMPTOMS COMPARED TO PLACEBO IN MEN ENROLLED IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDYJOURNAL OF UROLOGY, 2010, 183 (04): : E311 - E312Nickel, J. CurtisTammela, Teuvo L. J.Teloken, ClaudioWilson, Timothy H.Fowler, Ivy L.Rittmaster, Roger S.
- [6] REDUCTION IN SURGICAL AND NON-SURGICAL INTERVENTIONS FOR PROSTATE CANCER WITH DUTASTERIDE TREATMENT IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDYANNALS OF ONCOLOGY, 2010, 21 : 275 - 275Rittmaster, R.Montorsi, F.Marberger, M.Roehrborn, C.Andriole, G.Somerville, M.Castro, R.Fueyo, A.
- [7] EVALUATION OF SAFETY AND ABILITY OF DUTASTERIDE TO IMPROVE URINARY PARAMETERS IN SUBJECTS WITH LOW TESTOSTERONE IN THE REDUCTION BY DUTASTERIDE IN PROSTATE CANCER EVENTS (REDUCE) STUDYJOURNAL OF UROLOGY, 2013, 189 (04): : E564 - E565Marberger, MichaelFreedland, StephenRittmaster, RogerWilson, TimothyCastro, Ramiro
- [8] Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trialJOURNAL OF UROLOGY, 2004, 172 (04): : 1314 - 1317Andriole, GBostwick, DBrawley, OGomella, LTindall, DBreed, SSomerville, MRittmaster, R
- [9] Efficacy and Safety of Dutasteride on Prostate Cancer Risk Reduction in Asian Men: The Results from the REDUCE StudyJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : 417 - 423Akaza, HideyukiKanetake, HiroshiTsukamoto, TaijiMiyanaga, NaotoSakai, HidekiMasumori, NaoyaNakatsu, HiroomiSagiyama, KazuyukiSakamoto, SadaakiEndo, YukihiroYamanouchi, Takayoshi
- [10] THE INFLUENCE OF FAMILY HISTORY OF BREAST AND PROSTATE CANCER ON PROSTATE CANCER DIAGNOSES IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDYANNALS OF ONCOLOGY, 2010, 21 : 279 - 279Castro, R.Tammela, T.Andriole, G.Teloken, C.Rittmaster, R.Wilson, T.Fowler, I.Fueyo, A.